ReaGenics participates at CannaTech 2019 in Tel Aviv!
ReaGenics is thrilled to meet you on 1-2 April 2019 in Tel Aviv. We will have our boot with iCAN incubator. CannaTech is...
28 March, 2019
Contact
Problems with traditional cannabis cultivation
Expensive
Cost of machinery, facility, electricity, etc.
Difficult
Requires skilled workers
Time consuming
Whole plants take 6-12 weeks to flower
Unscalable
Yields are limited
Environmentally unsustainable
Uses large amounts of space and natural resources
Uncontrolled
Variations and contaminations in the environment make plants impossible to standardize
What’s the Solution?
Control all environmental factors by growing cannabis in a plant cell bio-reactor (PCBR)
About Our Technology
ReaGenics is pioneering a novel plant cell bioreactor process for the mass-scale multiplication of cannabinoids. This eliminates the need to grow plants on an industrial scale for pharma-grade, botanically- derived cannabinoids. Leveraging success with patented technology for multiplication and manipulation of lavender cells, ReaGenics is applying the same technology to cannabis, allowing for consistent, controllable, and patentable formulations.
ReaGenics anticipates production periods up to four times faster and projected costs considerably cheaper, than plant cultivation. Creating powdered biomass for active pharmaceutical ingredients or extracted to produce cannabinoid oils, Bio-Reactor Production will change the way we look at medical cannabis.
Contact Us To Learn More:
About the team
ReaGenics is an Israeli based company, with founders from Poland and Israel, bring the best IP to the most dynamic cannabis ecosystem. Conceived at CannaTech 2018, ReaGenics was founded in Israel to conduct research and development related to cannabis production technologies.
The company was founded by Rafal Slusarczyk, a Polish entrepreneur and biologist, and iCAN: Israel Cannabis, a globally recognized leader in the cannabis industry. iCAN CEO, Saul Kaye, is a pharmacist and entrepreneur and board member on ReaGenics.
Product Pipeline:
-Irritable bowel disease (IBD) formulation
-Formulations for other medical conditions to be determined in collaboration with expert physicians.
Award Winning!
Co-founder, Rafal Slusarczyk, won sponsorship from the European Union as a participant in the Erasmus for Young Entrepreneurs program. He is the first member of the program in Israel.
We are always on the lookout for investors and collaborators.
Blog
We invite you to read the latest information on current events .
-
-
ReaGenics at the Cannabis Tech Pitch Night
We’re excited to announce the 1st annual Cannabis Tech Pitch Night, organized by CannaImpact will take place on Fe...
25 February, 2019 -
JOIN US IN PANAMA! February 12-13, 2019
Join us at CannaTech Panama for high level networking and sophisticated cannabis conversation with cannabis leaders and ...
12 February, 2019
Contact
Contact us to discover opportunities!
ReaGenics
SUBS hub, 5 Hauman Street
Beit Shemesh, Israel
Tel. +972 53 5625475